Yüklüyor......
Multilocus genetic profiling to empower drug trials and predict brain atrophy()
Designers of clinical trials for Alzheimer's disease (AD) and mild cognitive impairment (MCI) are actively considering structural and functional neuroimaging, cerebrospinal fluid and genetic biomarkers to reduce the sample sizes needed to detect therapeutic effects. Genetic pre-selection, howev...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Elsevier
2013
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3777716/ https://ncbi.nlm.nih.gov/pubmed/24179834 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nicl.2013.05.007 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|